Hangzhou Tigermed Consulting Co., Ltd (SHE: 300347)
China
· Delayed Price · Currency is CNY
63.82
-1.00 (-1.54%)
Nov 15, 2024, 11:31 AM CST
Hangzhou Tigermed Consulting Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 958.67 | 2,025 | 2,007 | 2,874 | 1,750 | 841.63 | Upgrade
|
Depreciation & Amortization | 305.69 | 305.69 | 264.75 | 188.92 | 144.74 | 43.26 | Upgrade
|
Other Amortization | 33.34 | 33.34 | 20.1 | 7.84 | 5.51 | 3.99 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.19 | 0.19 | 0.09 | 0.53 | 0.89 | 0.38 | Upgrade
|
Asset Writedown & Restructuring Costs | 29.16 | 29.16 | 0.45 | - | - | - | Upgrade
|
Loss (Gain) From Sale of Investments | -690.95 | -690.95 | -638.61 | -2,128 | -1,422 | -364.82 | Upgrade
|
Provision & Write-off of Bad Debts | 36.68 | 36.68 | 23.86 | 25.72 | -11.97 | 26.51 | Upgrade
|
Other Operating Activities | 1,217 | 244.62 | 328.93 | 552.99 | 478.97 | 162.49 | Upgrade
|
Change in Accounts Receivable | -719.47 | -719.47 | -869.25 | -808.73 | -142.27 | -282.89 | Upgrade
|
Change in Inventory | -4.36 | -4.36 | -16.11 | -1.37 | -3.52 | -0.5 | Upgrade
|
Change in Accounts Payable | -111.55 | -111.55 | 193.78 | 575.03 | 104.79 | 114.82 | Upgrade
|
Change in Other Net Operating Assets | 16.09 | 16.09 | 50.53 | 92.26 | 36.8 | 40.77 | Upgrade
|
Operating Cash Flow | 1,057 | 1,150 | 1,358 | 1,424 | 998.68 | 527.56 | Upgrade
|
Operating Cash Flow Growth | -12.30% | -15.25% | -4.66% | 42.57% | 89.30% | 1.02% | Upgrade
|
Capital Expenditures | -378.86 | -313.76 | -448.6 | -368.62 | -156.5 | -102.91 | Upgrade
|
Sale of Property, Plant & Equipment | 0.7 | 5.31 | 2.02 | 1.43 | 0.69 | 3.36 | Upgrade
|
Cash Acquisitions | -28.05 | -351.29 | -663.09 | -318.46 | -193.52 | -71.95 | Upgrade
|
Divestitures | - | - | - | 67.1 | 4.84 | 32.9 | Upgrade
|
Investment in Securities | -5,365 | -972.68 | -1,779 | -2,156 | -1,867 | -512.64 | Upgrade
|
Other Investing Activities | 106.08 | 98.19 | 99.7 | -7.84 | -155.57 | 13.08 | Upgrade
|
Investing Cash Flow | -5,665 | -1,534 | -2,789 | -2,783 | -2,367 | -638.15 | Upgrade
|
Long-Term Debt Issued | - | 3,201 | 3,441 | 492.32 | 1,192 | 1,250 | Upgrade
|
Long-Term Debt Repaid | - | -2,666 | -1,953 | -90.58 | -2,095 | -1,071 | Upgrade
|
Net Debt Issued (Repaid) | 380.98 | 534.89 | 1,489 | 401.74 | -903.03 | 179.81 | Upgrade
|
Issuance of Common Stock | 211.42 | 395.55 | 339.12 | 288.94 | 11,212 | 1,441 | Upgrade
|
Repurchase of Common Stock | -29.85 | -29.85 | -426.6 | -515.95 | - | - | Upgrade
|
Common Dividends Paid | -627.84 | -589.87 | -492 | -284.23 | -271.3 | -265.97 | Upgrade
|
Other Financing Activities | -689.38 | -318.53 | -99.85 | -53.58 | -698.2 | 79.62 | Upgrade
|
Financing Cash Flow | -754.67 | -7.81 | 809.25 | -163.09 | 9,339 | 1,434 | Upgrade
|
Foreign Exchange Rate Adjustments | -35.12 | 8.79 | 26.93 | -59.56 | -47.48 | 15.2 | Upgrade
|
Net Cash Flow | -5,398 | -382.8 | -595.68 | -1,582 | 7,923 | 1,339 | Upgrade
|
Free Cash Flow | 677.7 | 836.68 | 908.9 | 1,055 | 842.18 | 424.65 | Upgrade
|
Free Cash Flow Growth | -21.77% | -7.95% | -13.86% | 25.29% | 98.32% | -1.37% | Upgrade
|
Free Cash Flow Margin | 9.96% | 11.33% | 12.83% | 20.24% | 26.38% | 15.15% | Upgrade
|
Free Cash Flow Per Share | 0.78 | 0.97 | 1.05 | 1.21 | 1.05 | 0.57 | Upgrade
|
Cash Income Tax Paid | 611.38 | 644.91 | 594.85 | 321.71 | 241.3 | 234.34 | Upgrade
|
Levered Free Cash Flow | -10.74 | 316.13 | -115.55 | 712.29 | 465.49 | 361.05 | Upgrade
|
Unlevered Free Cash Flow | 83.8 | 391.07 | -63.56 | 727.86 | 497.23 | 386.3 | Upgrade
|
Change in Net Working Capital | 733.4 | 710.97 | 1,048 | 23.36 | 77.12 | 40.54 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.